Professor Michael Kerin has been elected President of RCSI following the College’s biennial Council Elections, with a focus on strengthening collaboration between academic research and clinical practice.
The Irish Rhinologic Society has released a new Follow Your Nose podcast episode focusing on obstructive sleep apnea and the importance of early diagnosis and treatment.
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
The Irish Medical Organisation has criticised planned HSE spending and recruitment controls, warning they could negatively affect patient care and frontline healthcare delivery.
Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
The first authorised treatment for epidermolysis bullosa in Ireland has been made available, marking a major milestone for patients living with the painful rare skin condition.
Beacon Hospital has launched Ireland’s largest private rheumatology centre, offering integrated diagnostics, infusion therapies and multidisciplinary care to meet rising demand.
The Government has finalised new framework agreements with Medicines for Ireland and the Irish Pharmaceutical Healthcare Association to improve access to medicines and strengthen supply security.
Penthrox (methoxyflurane) is now licensed for use in children aged six and over in Ireland, expanding emergency trauma pain relief options in hospital and pre-hospital settings.